Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Contravir Pharmaceuticals, Inc.

NASDAQ: CTRVHealthcare / Biotechnology / USA
0.3300+0.0100+3.13%Vol 29 2181Y Perf -86.91%
Jan 18th, 2019 16:00
BID0.3300 ASK0.3400
Open0.3400 Previous Close0.3200
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.00 
Analyst Rating
Strong Buy 1.00
Potencial %
506.06 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)5 
Earnings Rating
Neutral
Price Range Ratio 52wk %
4.36 
Earnings Date
23rd May 2018

Today's Price Range

0.32000.3600

 

52wk Range

0.21002.96

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-8.33%
3 Months
-40.00%
6 Months
-65.63%
1 Year
-86.91%
3 Years
-95.75%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CTRV0.33000.01003.13
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.60
Current Ratio
1.60
Long Term Debt to Total Capital
-
Total Debt to Equity
0.58
Interest Coverage
-37.60
Leverage Ratio 8.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.64
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.60
Cash Flow Per Share
-1.23
Price to Tangible Book
-3.94
Book Value per Share
0.22
Enterprise Value (in ths.)
-18
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
381.04
ROE last 12 Months
-462.98
Return on Assets (5Y Avg)
-101.47
ROA last 12 Months
-122.23
Return on Capital (5Y Avg)
-
ROC last 12 Months
-601.38
Return on invested Capital Q
-295.20
Return on invested Capital Y
62.19
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.03-
Q03 2017-0.14-0.0842.86
Q02 2017-0.14-0.1121.43
Q01 2017-0.14-0.137.14
Q04 2016-0.15-0.16-6.67
Q03 2016-0.23-0.1439.13
Q02 2016-0.25-0.2020.00
Q03 2015-0.15-0.33-120.00
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.090.00-
6/2017 QR-0.140.00-
6/2018 FY-0.410.00-
6/2018 FY-0.410.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume29 218
Shares Outstanding (in ths.)16 567
Trades Count54
Dollar Volume10 077
Avg. Volume74 626
Avg. Weekly Volume55 768
Avg. Monthly Volume100 257
Avg. Quarterly Volume171 722

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

73%27%

Bearish Bullish

53%47%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News